Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

760 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Locoregional Control and Mild Late Toxicity After Reducing Target Volumes and Radiation Doses in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Treated With Induction Chemotherapy (IC) Followed by Concurrent Chemoradiotherapy: 10-Year Results of a Phase 2 Study.
Zhao C, Miao JJ, Hua YJ, Wang L, Han F, Lu LX, Xiao WW, Wu HJ, Zhu MY, Huang SM, Lin CG, Deng XW, Xie CH. Zhao C, et al. Among authors: wu hj. Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):836-844. doi: 10.1016/j.ijrobp.2019.03.043. Epub 2019 Apr 5. Int J Radiat Oncol Biol Phys. 2019. PMID: 30954521 Clinical Trial.
Long-term survival and late toxicities of elderly nasopharyngeal carcinoma (NPC) patients treated by high-total- and fractionated-dose simultaneous modulated accelerated radiotherapy with or without chemotherapy.
Miao J, Wang L, Zhu M, Xiao W, Wu H, Di M, Huang Y, Huang S, Han F, Deng X, Guo X, Zhao C. Miao J, et al. Oral Oncol. 2019 Feb;89:40-47. doi: 10.1016/j.oraloncology.2018.12.008. Epub 2018 Dec 18. Oral Oncol. 2019. PMID: 30732957 No abstract available.
Corrigendum to "Long-term survival and late toxicities of elderly nasopharyngeal carcinoma (NPC) patients treated by high-total- and fractionated-dose simultaneous modulated accelerated radiotherapy with or without chemotherapy" [Oral Oncol. 89 (2019) 40-47].
Miao J, Wang L, Zhu M, Xiao W, Wu H, Di M, Huang Y, Huang S, Han F, Deng X, Guo X, Zhao C. Miao J, et al. Oral Oncol. 2019 Mar;90:136. doi: 10.1016/j.oraloncology.2018.12.030. Epub 2019 Jan 26. Oral Oncol. 2019. PMID: 30853081 No abstract available.
760 results